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Abstract
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•One of the main reasons why regulation has to be present for assisted
human reproduction is the fear of eugenics. There has to be some kind of
authority that can establish limits
• With its high cost, procedures such as in vitro fertilization and
preimplantation genetic diagnosis can only be afforded by those of the higher
class. There will be a great imbalance in society if being wealthier began to
mean being healthier and superior in genetic structure.
• Like Ms. Suleman’s case, patients who do not have a considerable amount
of income could gain just enough money for the treatments. If their
treatments are successful, they still will not have enough money to support
their newborn children. This will not only be detrimental to the family that
these patients are in, but it also takes away from the community that will
support them through taxes.
• Others would argue that by choosing which embryos should develop and
eliminating the rest, humans would be doing what the nature of life is
supposed to be doing. This is more of an argument that begs for lines to be
drawn between the advancement of technology and the role of nature.
• If the future sees a widespread use of IVF and PGD, there will still be
people who will choose or have no choice but to give birth naturally without
any genetic enhancements. In a world with healthier and much fit humans,
normal babies will probably be discriminated against.

Designer babies have been frequently used to help prevent genetic defect of
offspring. The two main procedures that can help prevent offspring of having
a genetic defect is by IVF, In Vitro Fertilization, or PGD, Preimplantation
Genetic Disorder. It is a topic currently being debated ethically on whether it
is okay to design a baby and how far people may take the procedures to
design a baby before it gets out of hand. Two sides can be approached to this
topic: Should designer babies be regulated or should it not be regulated? A
concern that is plaguing the minds of many people is whether designing
babies will lead to the creation of a super race. There are 7.3 million women
(between ages 15-44) in the U.S. that are infertile. There are 2.1 million men
and women in the U.S. who cannot conceive a baby (within 12 consecutive
months).

Introduction
Designer babies is a term journalist coined to describe certain branches
in the field of assisted human reproduction. Its purpose and main goal is to
give parents more control over their offspring’s genetic outcome before they
are even born. Designer babies can be related to the popular dystopian novel,
A Brave New World. A Brave New World is a novel by Aldous Huxley
(published in 1928) that depicts a society 532 years from now in which they
create humans in bottles and those humans live pre-determined lives.
Humans are created by The Director of Hatcheries and Conditioning and by
the Bokanovsky’s Process. In this process, one egg is divided into a bud and
every bud grows into one embryo, which then grows into a full-sized adult.
96 babies come from one embryo.“During the gestation period the embryos
travel in bottles along a conveyor belt through a factory like building, and
are conditioned to belong to one of five castes: Alpha, Beta, Gamma, Delta,
or Epsilon.” (Sparknotes). This is similar to “Designer babies” in our world
today, in which we use processes similar to the Bokanovsky Process such as
In Vitro Fertilization and PGD and the Director of Hatcheries and
Conditioning are the doctors. This future has become more of a reality when
the first “test tube baby”, Louise Brown, was born on July 25, 1978 (Baird
12). She grew up to be as healthy as any normal baby could be. However, the
procedures of designing babies we know now are not limited to just
producing a healthy infant anymore. Embryos can be chosen so that the
parent(s) can have their offspring fit the preference they had in mind. This,
of course, provokes ethical questions such as the risk that the idea of
eugenics will return and be open for the public to explore. These procedures
are not available just in the United States, but as well as other countries such
as the United Kingdom and Canada. They have had their own experiences
with these treatments (Verlinsky 24). Designer babies are inevitable, sooner
or later its regulation would be a topic of importance.

In Vitro Fertilization
Louise Brown, the first “test tube baby”, was conceived with the help
of a process known as in vitro fertilization (IVF). The process involves
taking an egg cell(s) from the woman’s ovaries, exposing it to sperm outside
of the body, allowing fertilization, and putting a fertilized egg(s) back into
the woman’s uterus. It is a difficult process that requires money and patience
because of its low rate of success. There are many risks to IVF. By the end of
the experiment, 105 of 311 patients who underwent in vitro fertilization had
successful deliveries (Lowe). There were also 40 patients who were in the
middle of pregnancy at this time. Research shows that, in average, the
probability of a successful treatment decreases as the woman’s age increases
(American Pregnancy Association). Despite the low rate of success and the
burden it places on the mother, it's still a popular choice. One of the most
well known success stories of IVF involves a woman named Nadya
Suleman. Through IVF, she was able to give birth to octuplets. Suleman's
status as a single, unemployed woman presents difficulties when it comes to
caring for eight offspring (Scientific American). Legislators responded to this
by taking action at a state-level, but the same cannot be said for the federal
administration, which could establish some kind of regulation through the
health care reform (Scientific American). IVF is regulated in other countries.
In vitro fertilization is one of the few ways infertile couples could give birth
to a child, but it is not the only way. Two other well known procedures are
fertility medications and artificial insemination. Variations of IVF include
gamete intrafallopian transfer (GIFT) and zygote intrafallopian transfer
(ZIFT) (American Pregnancy Association). In vitro fertilization became the
foundation which preimplantation genetic diagnosis was added on to.
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Preimplantation Genetic Diagnosis
PGD, Preimplantation Genetic Disorder, is a reproductive procedure that helps prevent birth
defects and avoid genetic diagnosis or termination of pregnancy. It was discovered by Edwards
and Gardner in 1968, but didn’t show true success until 1990. PGD can be used to screen X-linked
diseases, and chromosome translocations. It can help prevent diseases such as Tay - Sachs disease,
Cystic Fibrosis, and Spinal Atrophy. There have been cases where it has been used for sex
selection, but has been prohibited in many countries where PGD is allowed. There have been over
1000 live born children after treatment of PGD. The average cost of the 1st cycle of PGD is about
$6000 and repeated cycles are about $4500. Preimplantation Genetic Disorder also helps with
having an unaltered embryo from the beginning stages of pregnancy resulting in a healthy
offspring, but requires the use of IVF. It holds 2 distinct purposes: aneuploidy screening to
enhance In Vitro Fertilization success, the most common reason used, and detection of genetic
disorders when family members are known to have or carry the disease. There a three major
approaches to PGD: testing of eggs by removing the first and second polar bodies (PB1 and PB2),
which is the secondary product of the division process in meiosis. This all occurs before the egg is
matured and before the embryo is formed, embryo biopsy at day 3, and embryo biopsy at day 5.
The general process of PGD involves one or two cells obtained from a 6-10 cell stage embryo, a
stage reached 3days after insemination, or polar body biopsy. A past technique that has been used
is zona pellucida is penetrated using acid or laser technology or two blastomeres are aspirated with
a biopsy pipette. PCR (polymerase chain reaction) is then used to amplify DNA to detect singlegene diseases. Extreme precaution must be taken because contamination is crucial. In order for
chromosomal analysis to be determined, Fluorescence in-situ hybridization must be used. A
second technique, which is simpler and requiring less technology, is Polar body biopsy. Polar body
biopsy can be done before fertilization by making a slit in the zona pellucida and drawing at the
polar body of the egg with a biopsy pipette. Polar body biopsy only helps to determine the disease
is found only for the maternal genes and may be unreliable. If these two procedures do not work,
you can then use 2nd polar body, in which eggs are forced out after fertilization and after the
completion of the meiotic division, (reproductive division of cells). There have been a few
concerns about PGD. Some feel that the selection process and the perceived danger of creating
designer babies. Many feel there should be a public discussion on what the acceptable and
unacceptable limits for this technique should be (Lancet 1-3).
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Why shouldn’t Designer Babies be regulated?
• Even though the Pro-choice movement has different goals to those fighting against
designer baby regulation, they still share the two most powerful things that support
their causes: choice and privacy. Designer babies should not be controlled by any
kind of authority because it is the women’s choice to undergo the procedures and
that hardly has anything to do with anyone else.
• PGD could help families who have had a long history of inherited diseases. With
the diseased embryos eliminated, these families would no longer have to suffer the
physical, emotional, and financial strain brought on by these ailments.
• Without any interference from outside organizations, researchers could study the
human genetic makeup more efficiently and at a faster pace. The more the scientists
find out about what each gene does and which changes have effects on them, the
better they can prevent diseases from occurring.

Conclusion
It is understood that many couples do not wish to conceive a genetic
defective child due to the hardships that come with having a genetically
defective child. Designing a baby to help prevent birth defects is an ethically
just reason to do so. Even though IVF and PGD do not guarantee healthy
babies, the rapid growth of technology in this field of study, can cause many
couples to go to the extreme to creating a perfect child. This can be proven
to be an unethical reason to design a baby. If your child is already healthy
why should you perfect them even more? There have been laws made in the
UK, a popular country that uses both IVF and PGD regularly, which only
gave licenses for using PGD for specific diseases such as, cystic fibrosis,
hemophilia, Beta- thalassaemia, sickle-cell disease, Duchennes muscular
dystrophy, fragile X-retardation, and Huntington’s disease.
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